These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9669490)

  • 1. Neuropeptide Y Y1 receptors in vascular pharmacology.
    Franco-Cereceda A; Liska J
    Eur J Pharmacol; 1998 May; 349(1):1-14. PubMed ID: 9669490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM; Modin A
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of the sympathetic perimesenteric arterial nerves releases neuropeptide Y potentiating the vasomotor activity of noradrenaline: involvement of neuropeptide Y-Y1 receptors.
    Donoso MV; Brown N; Carrasco C; Cortes V; Fournier A; Huidobro-Toro JP
    J Neurochem; 1997 Sep; 69(3):1048-59. PubMed ID: 9282927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
    Malmström RE
    Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction.
    Han S; Yang CL; Chen X; Naes L; Cox BF; Westfall T
    Am J Physiol; 1998 Jan; 274(1):H290-4. PubMed ID: 9458879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sympathetic regulation of skeletal muscle blood flow in the pig: a non-adrenergic component likely to be mediated by neuropeptide Y.
    Modin A; Pernow J; Lundberg JM
    Acta Physiol Scand; 1993 May; 148(1):1-11. PubMed ID: 8333291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A
    Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
    Pernow J
    Acta Physiol Scand Suppl; 1988; 568():1-56. PubMed ID: 3232527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple neuropeptide Y receptors are involved in cardiovascular regulation. Peripheral and central mechanisms.
    Grundemar L; Håkanson R
    Gen Pharmacol; 1993 Jul; 24(4):785-96. PubMed ID: 8224732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine 5'-triphosphate and neuropeptide Y are co-transmitters in conjunction with noradrenaline in the human saphenous vein.
    Racchi H; Irarrázabal MJ; Howard M; Morán S; Zalaquett R; Huidobro-Toro JP
    Br J Pharmacol; 1999 Mar; 126(5):1175-85. PubMed ID: 10205006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo.
    Malmström RE; Balmér KC; Lundberg JM
    Br J Pharmacol; 1997 Jun; 121(3):595-603. PubMed ID: 9179405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
    Malmström RE; Lundberg JN; Weitzberg E
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed.
    Donoso MV; Steiner M; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1997 Aug; 282(2):691-8. PubMed ID: 9262332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y receptor subtypes, Y1 and Y2.
    Wahlestedt C; Grundemar L; Håkanson R; Heilig M; Shen GH; Zukowska-Grojec Z; Reis DJ
    Ann N Y Acad Sci; 1990; 611():7-26. PubMed ID: 2174225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y: multiple receptors and multiple roles in cardiovascular diseases.
    Pons J; Lee EW; Li L; Kitlinska J
    Curr Opin Investig Drugs; 2004 Sep; 5(9):957-62. PubMed ID: 15503651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?
    Zukowska Z; Pons J; Lee EW; Li L
    Can J Physiol Pharmacol; 2003 Feb; 81(2):89-94. PubMed ID: 12710520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y and sympathetic neurotransmission.
    Lundberg JM; Franco-Cereceda A; Lacroix JS; Pernow J
    Ann N Y Acad Sci; 1990; 611():166-74. PubMed ID: 2174218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathetic vascular control of the laryngeo-tracheal, bronchial and pulmonary circulation in the pig: evidence for non-adrenergic mechanisms involving neuropeptide Y.
    Franco-Cereceda A; Matran R; Alving K; Lundberg JM
    Acta Physiol Scand; 1995 Oct; 155(2):193-204. PubMed ID: 8669292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent effects of ischaemia on neuropeptide Y mechanisms in pig renal vascular control in vivo.
    Malmström RE; Lundberg JM
    Acta Physiol Scand; 1997 Nov; 161(3):327-38. PubMed ID: 9401585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.